Abundance Wealth Counselors Has $903,000 Stock Position in SPDR S&P Biotech ETF $XBI

Abundance Wealth Counselors lowered its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 93.9% during the 2nd quarter, Holdings Channel.com reports. The firm owned 10,894 shares of the exchange traded fund’s stock after selling 167,832 shares during the quarter. Abundance Wealth Counselors’ holdings in SPDR S&P Biotech ETF were worth $903,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the stock. Ping Capital Management Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 5.3% during the second quarter. Ping Capital Management Inc. now owns 6,000 shares of the exchange traded fund’s stock valued at $498,000 after purchasing an additional 300 shares during the period. Madrona Financial Services LLC acquired a new position in shares of SPDR S&P Biotech ETF during the second quarter valued at about $10,424,000. Meridian Investment Counsel Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 3.7% during the second quarter. Meridian Investment Counsel Inc. now owns 13,206 shares of the exchange traded fund’s stock valued at $1,095,000 after purchasing an additional 470 shares during the period. Investment Partners Asset Management Inc. raised its holdings in shares of SPDR S&P Biotech ETF by 4.0% during the second quarter. Investment Partners Asset Management Inc. now owns 3,257 shares of the exchange traded fund’s stock valued at $270,000 after purchasing an additional 125 shares during the period. Finally, Perigon Wealth Management LLC raised its holdings in shares of SPDR S&P Biotech ETF by 39.7% in the 2nd quarter. Perigon Wealth Management LLC now owns 6,720 shares of the exchange traded fund’s stock worth $557,000 after acquiring an additional 1,910 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

XBI opened at $102.59 on Friday. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $105.47. The firm has a market capitalization of $5.85 billion, a PE ratio of 11.47 and a beta of 0.97. The company’s 50-day moving average is $91.78 and its 200 day moving average is $85.05.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.